Summary of opinion: Opdivo, 27/03/2025 Positive
On 27 March 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending a change to the terms of the marketing authorisation for the medicinal product Opdivo. The marketing authorisation holder for this …